You are viewing: North America Veterinary Contract Manufacturing & Research Market analysis

The North America Veterinary Contract Manufacturing & Research Market was valued at $395.1 Million in 2026 and projected to reach to $579.5 Million by 2031, representing a compound annual growth rate of 8.0%. North America's veterinary contract manufacturing and research market is positioned for sustained growth through 2031, driven by escalating demand for specialized pharmaceutical formulations and biologics tailored to companion animal and livestock sectors.

North America Veterinary Contract Manufacturing & Research Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Veterinary Contract Manufacturing & Research Market Trends and Insights

  • North America's market growth is driven by increasing demand for specialized veterinary pharmaceuticals, biologics, and research services across the region.
  • The expansion in North America is supported by robust regulatory frameworks, advanced manufacturing infrastructure, and rising investment in animal health innovation throughout the forecast period..

Key Market Statistics

  • CAGR (2026-2031) 8.0% CAGR
  • Market Size, 2026 ~USD 395.1 Million
  • Forecast, 2031 ~USD 579.5 Million
  • Geography North America

North America Veterinary Contract Manufacturing & Research Market Overview

Market Valuation & Growth :

North America's veterinary contract manufacturing and research market is valued at $395.1 million in 2026, with projected expansion to $579.5 million by 2031, representing an 8.0% CAGR—outpacing the global growth rate of 7.7%.

US Market Dominance :

The United States commands the largest share of North America's market at $511.7 million, driven by advanced pharmaceutical infrastructure, robust R&D investments, and stringent regulatory standards for veterinary products.

Specialized Pharmaceutical Demand :

Increasing demand for specialized veterinary pharmaceuticals, biologics, and research services across North America is fueling market expansion, supported by growing pet ownership and livestock health management initiatives.

Regional Expansion Opportunities :

Canada ($67.8 million) and Mexico ($11.9 million) present emerging growth opportunities, with rising investments in veterinary research infrastructure and contract manufacturing capabilities throughout the region.

North America Veterinary Contract Manufacturing & Research Market Dynamics

  • The region's advanced regulatory framework, established manufacturing infrastructure, and significant R&D investments create a competitive advantage for contract service providers.
  • Consolidation among veterinary pharmaceutical companies and increased outsourcing of manufacturing and research functions are expected to accelerate market expansion.
  • The US remains the primary growth engine, while Canada and Mexico offer secondary expansion opportunities as veterinary healthcare standards align with North American norms. Key growth catalysts include rising pet healthcare expenditures, increasing prevalence of zoonotic diseases, and growing adoption of advanced biologics and personalized veterinary treatments.
  • Investment in contract research organizations (CROs) specializing in veterinary applications, coupled with regulatory harmonization efforts across North America, will further strengthen market dynamics.
  • Strategic partnerships between pharmaceutical manufacturers and contract service providers are anticipated to enhance service offerings and market penetration throughout the region..

Related Ecosystem

Animal Health

Top Technologies
    Top Companies

      Key Takeaways

      • North America's veterinary contract manufacturing market is valued at $395.1 million in 2026 with projected growth to $579.5 million by 2031.
      • North America demonstrates an 8.0% CAGR, outpacing the global average of 7.7%, indicating strong regional market momentum.
      • North America's advanced regulatory environment and manufacturing capabilities position it as a leading hub for veterinary contract services.
      • North America's market expansion is fueled by increasing outsourcing of R&D and manufacturing by veterinary pharmaceutical companies.

      Veterinary Contract Manufacturing & Research Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment CDMO SERVICES (Service)
      Forecast Period 2026–2031
      Growth Rate CAGR of 7.7% from 2026 to 2031
      Largest Segment CDMO SERVICES (Service)
      Market Size Base Year (Billions) ~USD 6.38 (2026)
      Revenue Forecast (Billions) ~USD 9.24 (2031)
      Segments Covered Service, Type

      North America Veterinary Contract Manufacturing & Research Market Report Segmentation

      2 segment dimensions are covered across the global market.

      By Service

      • Cdmo Services
      • Cro Services

      By Type

      • Analytical & Bioanalytical Services And Quality Assurance
      • Discovery & Pre-Clinical Studies
      • Manufacturing
      • Packaging & Labeling
      • Process Api & Formulation Development
      • Quality/Stability & Post-Market Support
      • Regulatory Affairs & Consulting
      • Veterinary Clinical Trials

      Target Audience

      • Veterinary Pharmaceutical Manufacturers : Manufacturers seeking to outsource production and R&D require detailed market intelligence on North American contract service capabilities, pricing benchmarks, and regulatory compliance standards to optimize supply chain decisions.
      • Contract Manufacturing Organizations (CMOs) : CMOs operating in North America need market sizing data, competitive positioning analysis, and growth forecasts to identify expansion opportunities, justify capacity investments, and benchmark performance against regional peers.
      • Contract Research Organizations (CROs) : Veterinary CROs require insights into North American research demand, therapeutic focus areas, and client procurement patterns to develop service portfolios, target high-value segments, and support business development initiatives.
      • Private Equity & Investment Firms : Investors evaluating acquisition targets or portfolio companies in veterinary contract services need comprehensive market data, growth trajectories, and competitive dynamics across North America to assess investment returns.
      • Regulatory & Compliance Consultants : Consultants advising veterinary companies on North American market entry require detailed regulatory landscape analysis, compliance requirements by country, and market-specific operational best practices.

      North America vs. other regions

      HowNorth America compares to the other 3 regional blocs covered in this market.

      Europe
      ~USD 503.5 Million · 7.4% wtd CAGR ·
      Asia Pacific
      ~USD 323.7 Million · 9.1% wtd CAGR ·

      Countries within North America - compare and drill down

      Country2025 size (native)
      USUSD 511.7 Million
      CanadaUSD 67.8 Million
      MexicoUSD 11.9 Million

      Country market size visualization

      US
      USD 511.7 Million
      Canada
      USD 67.8 Million
      Mexico
      USD 11.9 Million

      Reasons to Buy this Report

      • Regional Market Sizing & Forecasts : Obtain precise market valuations for North America ($395.1M in 2026) and country-level breakdowns for the US, Canada, and Mexico with detailed 5-year projections to support strategic planning and investment decisions.
      • Competitive Landscape Analysis : Understand the competitive positioning of contract manufacturers and research providers across North America, identifying market leaders, emerging players, and consolidation trends shaping the industry.
      • Growth Driver Identification : Gain insights into region-specific growth catalysts including pet ownership trends, livestock health regulations, pharmaceutical outsourcing patterns, and R&D investment flows unique to North American markets.
      • Regulatory & Compliance Insights : Access detailed analysis of FDA, Health Canada, and Mexican regulatory frameworks governing veterinary contract manufacturing, enabling compliant market entry and operational optimization.
      • Strategic Partnership Opportunities : Identify high-potential collaboration and acquisition targets among North American contract manufacturers, CROs, and veterinary pharmaceutical companies based on market share and capability assessments.

      Frequently asked questions

      What is the current size of the North America veterinary contract manufacturing market?

      In 2026, North America's veterinary contract manufacturing and research market is valued at $395.1 million USD.

      What is the projected market size for North America by 2031?

      North America's veterinary contract manufacturing market is forecast to reach $579.5 million USD by 2031.

      What is the growth rate for North America's veterinary contract manufacturing market?

      North America's market is expected to grow at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2031.

      How does North America's growth compare to the global market?

      North America's 8.0% CAGR exceeds the global average of 7.7%, demonstrating stronger regional growth momentum in veterinary contract services.

      What factors are driving growth in North America's veterinary contract manufacturing market?

      Growth in North America is driven by increased outsourcing of R&D and manufacturing, advanced regulatory frameworks, and rising investment in animal health innovation.

      RESEARCH METHODOLOGY

      This research study extensively utilized both primary and secondary sources. It involved analyzing various factors that influence the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and the strategies employed by key players.

      Secondary Research

      This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary contract manufacturing & research market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments about both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

      Primary Research

      In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development, and operations managers, as well as presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary contract manufacturing & research market. Primary sources from the demand side include R&D scientists and researchers in animal health companies, veterinary clinicians, and veterinary biotech firms developing veterinary therapeutics and technologies.

      Veterinary Contract Manufacturing and Research Market 
 Size, and Share

      Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
      Note 2: Other designations include sales, marketing, and product/service managers.

      Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The total size of the veterinary contract manufacturing & research market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

      Veterinary Contract Manufacturing and Research Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the veterinary contract manufacturing & research market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and obtain precise statistics for all segments and subsegments.

      Market Definition

      The veterinary contract research organization (CRO) market comprises third-party service providers that support animal-health companies in the outsourced research and development of veterinary pharmaceuticals, biologics, vaccines, and related products. Veterinary CROs provide services across the product lifecycle, including discovery support, preclinical studies, target animal safety, clinical field trials, bioequivalence studies, regulatory consulting, and post-approval research, in compliance with veterinary regulatory standards. These services are primarily used by animal-health pharmaceutical companies, biotechnology firms, and vaccine developers to reduce development timelines, access specialized expertise, manage regulatory complexity, and optimize R&D costs without maintaining a complete in-house research infrastructure. The veterinary contract development and manufacturing organization (CDMO) market consists of third-party manufacturers that provide outsourced development, scale-up, and commercial manufacturing services for veterinary drugs, biologics, vaccines, and related products. Veterinary CDMOs support animal-health companies through process and formulation development, API and finished dosage form manufacturing, fill-finish operations, packaging and labeling, quality control, stability testing, and regulatory manufacturing support, operating in accordance with veterinary GMP and biologics regulations.

      These services enable animal-health companies to outsource capital-intensive manufacturing activities, increase production flexibility, manage capacity constraints, and accelerate market entry, particularly for complex formulations, sterile injectables, and veterinary vaccines.

      Key Stakeholders

      • Animal-health pharmaceutical companies
      • Veterinary biotechnology companies
      • Veterinary biologics & vaccine developers
      • Veterinary contract development & manufacturing organizations (CDMOs)
      • Veterinary contract research organizations (CROs)
      • Preclinical & toxicology research laboratories (GLP & non-GLP)
      • Clinical trial management organizations for veterinary studies
      • Regulatory consulting firms specializing in VICH / EMA / FDA-CVM
      • Quality control & analytical testing laboratories (veterinary-focused)
      • Veterinary formulation & process development service providers
      • Packaging, filling, and labeling service providers for veterinary products
      • Animal research facilities & field trial centers
      • Veterinary academic research institutes
      • Livestock research institutions & herd-health trial networks
      • Raw material suppliers for veterinary APIs, excipients, and biologics components

      Report Objectives

      • To define, describe, segment, and forecast the veterinary contract manufacturing & research market by service, product type, animal type, end user, and region
      • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall veterinary contract manufacturing & research market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the veterinary contract manufacturing & research market in five central regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players in the veterinary contract manufacturing & research market and comprehensively analyze their core competencies and market shares
      • To track and analyze competitive developments such as acquisitions, service launches, expansions, collaborations, agreements, and partnerships

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

      Company Information
      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe veterinary contract manufacturing & research market into Austria, Finland, Switzerland, and other countries
      • Further breakdown of the Rest of Latin American veterinary contract manufacturing & research market into Colombia, Chile, and other countries
      Competitive Landscape Assessment
      • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary contract manufacturing & research market
      • Competitive leadership mapping for established players in the US

       

      Get the Full Veterinary Contract Manufacturing & Research Market Report

      Full forecast, segment splits, and company analysis for all Veterinary Contract Manufacturing & Research Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status